Sara-Megumi Rumrill, MD

Article

Pembrolizumab-Induced Type 1 Diabetes in a 95-Year-Old Veteran With Metastatic Melanoma

Author:: Sara-Megumi Rumrill, MD

Publish date: November 5, 2021

Low C-peptide levels should prompt a high suspicion for immune checkpoint inhibitor-induced type 1 diabetes, and initiation of insulin therapy shou...